Maki

MakiPeople is an AI-powered recruitment platform that assesses candidates' skills through immersive, conversational experiences, helping companies build diverse and efficient teams.

Headquarters

Year Founded

Search Tags

AI recruitment platform, Bias-free recruitment, HR technology solutions, Skills-based hiring, Talent assessment software

About Us

Maki is an AI-powered recruitment platform that revolutionizes the hiring process. The company offers a comprehensive solution for assessing candidates’ skills, identifying talent, and building diverse, efficient teams. Their technology utilizes artificial intelligence to create immersive and conversational assessment experiences, making recruitment more accurate, efficient, and enjoyable for both employers and job seekers. MakiPeople’s platform also helps organizations identify strengths and development areas within their current workforce, enabling informed decisions on career development and talent management.

Trending Companies

Latest Articles

Engineer intelligent, AI-driven supply chain operations. Discover what next-generation leaders must master to design resilient, data-driven, high-performing global networks.

The Future of Supply Chain Leadership: Why the Next Generation Will Engineer Intelligence, Not Just Manage It

Supply chain leadership is being redefined by AI, intelligent automation, and agentic decision-making, demanding leaders who can engineer end-to-end intelligence rather than simply manage workflows. This article explores how next-generation supply chain leaders will combine data, algorithms, and human judgment to build resilient, adaptive, and high-performing global operations.

Read More >
Medicare will pilot AI-driven prior authorization in 2026 across six states, targeting high-risk services while clinicians make final decisions.

AI-Powered Prior Authorization Comes to Traditional Medicare

Traditional Medicare will pilot AI-assisted prior authorization in 2026 across six states, focusing on high-risk outpatient services. Clinicians retain final say, but incentives and access concerns loom as CMS tests fraud reduction and “gold card” exemptions. Here’s what providers and patients should know.

Read More >